Select Protocol Intensity
STANDARDInjection (SubQ)
Bioavailability: ~100%Oral / Liposomal
Bioavailability: VariableTitration Schedule Visualization
Recommended ramp-up schedule to mitigate side effects (flushing, abdominal discomfort). This chart updates based on the selected protocol above.
Treatment Duration & Cycling
Continuous use may downregulate endogenous production. Cycling is recommended.
Clinical Notes:
- Washout: 2-4 weeks usually sufficient to reset receptors.
- Maintenance: Once target tissue levels reached, frequency can often drop to 1-2x/week maintenance inj.
- Side Effects: If nausea occurs, reduce dose by 25% and hold for 1 week.
Vial Longevity Calculator
Estimate prescription duration based on concentration and dose.
Total Doses per Vial
40
At 3x/week = 13.3 weeks supply
Contraindications & Cautions
Active Cancer: Theoretical risk of fueling tumor growth via PARP pathways. Avoid in active oncological cases.
Methylation Status: NAD+ metabolism consumes methyl groups. Consider co-prescribing TMG (Trimethylglycine).
Pregnancy/Lactation: Insufficient safety data.